Incorporated in 1995, Agilus Diagnostics Limited provides diagnostics testing services (routine and specialised tests), wellness and preventive care packages, hospital laboratory management services and clinical research trial testing services. It is the largest diagnostics service provider by the number of laboratories and the second largest in terms of revenue from operations in India as of March 31, 2023.
The company operates a network of 413 laboratories, out of which 43 laboratories were accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). It has expanded an extensive diagnostics network across 25 states and 5 union territories (UT) in India. With this rich presence, the company covers 1,000 towns and cities and over 532 districts in India as of March 31, 2023.
The healthcare industry has become one of the leading contributors to the economy. The industry growth is likely to witness growth due to numerous factors, such as the ageing population, rising middle class, increasing incidence of lifestyle diseases, and adoption of technology. The healthcare industry, which comprises pharmaceuticals, hospitals, medical devices, diagnostics, and health insurance, is likely to grow at a CAGR of between 10-11% during FY 2017-2023.
Agilus Diagnostics Limited IPO Details
Agilus Diagnostics Limited IPO Dates
Retail investors can bid for the Agilus Diagnostics Limited IPO. The issue date has not been announced yet.
Agilus Diagnostics Limited IPO Price Band
Agilus Diagnostics Limited is a 100% offer for sale (OFS). The OFS comprises 1,42,33,964 shares. It is a book-building issue. The price range has not been announced yet.
Agilus Diagnostics Limited IPO Lot Size
The lot size and minimum investment of Agilus Diagnostics Limited's IPO will be announced later.
Agilus Diagnostics Limited IPO Objectives
As per DRHP, the proceeds from the offer will go to selling shareholders. The company will not receive any proceeds from the offer. The objectives of the offer are:
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges
- Carry out the OFS of up to 1,42,33,964 shares.
Peer Details
As per DRHP, Agilus Diagnostics Limited has 4 listed peers.
- Dr Lal Path Labs.
- Metropolis.
- Thyrocare.
- Vijaya Diagnostic.
How To Check the Allotment Status of the Agilus Diagnostics Limited IPO?
Steps to check IPO allotment status on Angel One’s app:
- Log in to the Angel One app.
- Go to the IPO Section and then to IPO Orders.
- Select the individual IPO that you had applied for and check the allotment status.
- Angel One will notify you of your IPO allotment status via push notification and email.
Contact Details of Agilus Diagnostics Limited
Registered office: Fortis Hospital, Sector 62, Phase –VIII, Mohali - 160 062, Punjab, India
Phone: 0124-6261111
E-mail: investors@agilus.in
IPO Financials
| Particulars | Year ending on March 31, 2023 | Year ending on March 31, 2022 | Year ending on March 31, 2021 |
|---|---|---|---|
| Total Income | 13,711.02 | 16,183.47 | 10,606.94 |
| Profit After Tax (PAT) | 1,166.36 | 5,547.08 | 1,312.45 |
| Total Assets | 24,187.44 | 22,799.63 | 15,863.12 |
| Total Borrowings | 28.29 | 22.51 | 12.53 |
Know before investing
Strengths
2The company is an experienced pan-India diagnostics service provider with a diversified presence and a growing network. The company believes that it is well-positioned to capitalise on the expected growth in the Indian diagnostics industry.
Looking forward, the company will be focused on driving further utilisation of existing infrastructure to yield operating leverage.
Risks
2The company’s promoter ‘Fortis Healthcare Limited’ is facing legal proceedings. Any unfavourable outcome from the litigation could impact the business's resilience.
The company is exposed to risks arising from failure to introduce new tests and services, which could negatively affect its business, results of operations and financial condition.
